1. Home
  2. MESO vs AMPL Comparison

MESO vs AMPL Comparison

Compare MESO & AMPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mesoblast Limited

MESO

Mesoblast Limited

HOLD

Current Price

$14.52

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Amplitude Inc.

AMPL

Amplitude Inc.

HOLD

Current Price

$13.30

Market Cap

1.6B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
MESO
AMPL
Founded
2004
2012
Country
Australia
United States
Employees
108
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.6B
IPO Year
2005
2021

Fundamental Metrics

Financial Performance
Metric
MESO
AMPL
Price
$14.52
$13.30
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
12
Target Price
N/A
★ $13.42
AVG Volume (30 Days)
157.0K
★ 1.4M
Earning Date
02-26-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 11.84
EPS
★ N/A
N/A
Revenue
N/A
★ $343,214,000.00
Revenue This Year
$629.74
$17.43
Revenue Next Year
$30.65
$14.16
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 14.68
52 Week Low
$13.05
$5.51
52 Week High
$21.50
$14.76

Technical Indicators

Market Signals
Indicator
MESO
AMPL
Relative Strength Index (RSI) 39.88 53.64
Support Level $14.18 $6.05
Resistance Level $16.06 $13.58
Average True Range (ATR) 0.42 0.67
MACD -0.08 -0.09
Stochastic Oscillator 13.93 56.01

Price Performance

Historical Comparison
MESO
AMPL

About MESO Mesoblast Limited

Mesoblast Ltd is a commercial-stage biotechnology company engaged in developing and commercializing allogeneic (off-the-shelf) cellular medicines for severe inflammatory conditions. Its commercial product, Ryoncil (remestemcel-L-rknd), is FDA-approved for steroid-refractory acute graft-versus-host disease in pediatric patients. The company is also developing Ryoncil for additional inflammatory indications. Its rexlemestrocel-L platform is being developed for chronic low back pain associated with degenerative disc disease and chronic heart failure. The company operates as a single segment focused on its allogeneic cellular medicines platform.

About AMPL Amplitude Inc.

Amplitude Inc is a Software company that provides a Digital Analytics Platform that helps companies analyze their customer behavior within digital products. The Company delivers its application over the Internet as a subscription service using a software-as-a-service (SaaS) model and also it offers customer support related to initial implementation setup, ongoing support services, and application training. The company generates revenue through selling subscriptions to the platform. The company derives a majority of its revenue from the United States, and also has its presence in Internationally.

Share on Social Networks: